Continued use of trastuzumab (TRZ) beyond disease progression in the National Comprehensive Cancer Network (NCCN) Wong, Y., Ottesen, R., Niland, J., Hughes, M., Theriault, R., Edge, S., Blayney, D., Weeks, J. C. AMER SOC CLINICAL ONCOLOGY. 2008

View details for DOI 10.1200/jco.2008.26.15_suppl.6522

View details for Web of Science ID 000208457402376